“Repurposing Kinase Inhibitors for COVID-19 A Comprehensive Review of Antiviral and Immunomodulatory Effects” (2024) International Journal of Pharmaceutical and Healthcare Innovation, 1(03), pp. 217–226. doi:10.62752/.